BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23624255)

  • 1. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
    Simon L; Ospina J
    Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
    Simon L; Loney NW
    Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-dimensional mathematical model of percutaneous drug absorption.
    George K; Kubota K; Twizell EH
    Biomed Eng Online; 2004 Jun; 3(1):18. PubMed ID: 15202943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of epidermal turnover on the dynamics of percutaneous drug absorption.
    Simon L; Kim KS; Kanneganti K
    Math Biosci; 2011 Jan; 229(1):16-21. PubMed ID: 21040736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A random walk method for percutaneous drug absorption pharmacokinetics: application to repeated administration of a therapeutic timolol patch.
    Kubota K; Koyama E; Yasuda K
    J Pharm Sci; 1991 Aug; 80(8):752-6. PubMed ID: 1791535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin.
    Soni S; Dixit VK
    Pharmazie; 1994 Jan; 49(1):73-4. PubMed ID: 8140139
    [No Abstract]   [Full Text] [Related]  

  • 8. Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin.
    Cevc G; Vierl U
    J Control Release; 2007 Mar; 118(1):18-26. PubMed ID: 17254662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated applications of a transdermal patch: analytical solution and optimal control of the delivery rate.
    Simon L
    Math Biosci; 2007 Oct; 209(2):593-607. PubMed ID: 17490691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal timolol delivery from a Pluronic gel.
    Stamatialis DF; Rolevink HH; Koops GH
    J Control Release; 2006 Nov; 116(2):e53-5. PubMed ID: 17718968
    [No Abstract]   [Full Text] [Related]  

  • 11. A two-phase two-layer model for transdermal drug delivery and percutaneous absorption.
    Pontrelli G; de Monte F
    Math Biosci; 2014 Nov; 257():96-103. PubMed ID: 24835077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water-activated, pH-controlled patch in transdermal administration of timolol. I. Preclinical tests.
    Sutinen R; Paronen P; Urtti A
    Eur J Pharm Sci; 2000 Jul; 11(1):19-24. PubMed ID: 10913749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lag time in the dual sorption model for percutaneous absorption with finite skin-receptor boundary clearance.
    Twizell EH; Kubota K
    Math Biosci; 1994 Sep; 123(1):1-23. PubMed ID: 7949743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of diffusion with partitioning in stratum corneum using a finite element model.
    Barbero AM; Frasch HF
    Ann Biomed Eng; 2005 Sep; 33(9):1281-92. PubMed ID: 16133933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of timolol by electroporation through human skin.
    Denet AR; Préat V
    J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water-activated, pH-controlled patch in transdermal administration of timolol. II. Drug absorption and skin irritation.
    Sutinen R; Paronen P; Saano V; Urtti A
    Eur J Pharm Sci; 2000 Jul; 11(1):25-31. PubMed ID: 10913750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover.
    Simon L; Goyal A
    J Pharm Sci; 2009 Jan; 98(1):187-204. PubMed ID: 18481307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finite dose percutaneous drug absorption: theory and its application to in vitro timolol permeation.
    Kubota K; Yamada T
    J Pharm Sci; 1990 Nov; 79(11):1015-9. PubMed ID: 2292763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.
    Zghoul N; Fuchs R; Lehr CM; Schaefer UF
    ALTEX; 2001; 18(2):103-6. PubMed ID: 11378682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On mathematical modeling of dermal and transdermal drug delivery.
    Manitz R; Lucht W; Strehmel K; Weiner R; Neubert R
    J Pharm Sci; 1998 Jul; 87(7):873-9. PubMed ID: 9649357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.